Therapeutics, the company that helped to create Dolly, the world’s first cloned
sheep, is to shed up to 90 per cent of its staff.
biotechnology firm announced the move after a project to develop treatment for
lung disorders was dropped by its German partners.
the German drugs giant, put the programme to commercialise the new medicine AAT
– made from the milk of genetically modified sheep – on hold for at least three
PPL will lay off between 90 and 140 staff. Chief executive Geoff Cook said the
decision had no reflection on "the significant endeavours of our